Pablo D. Hendler

Pablo Hendler recently joined Jones Day bringing with him extensive experience in all aspects of litigation, involving a broad range of technologies, particularly life science patent litigation. He has a unique combination of skills as a research chemical engineer, inventor, and attorney with more than 20 years of experience in patent infringement litigation, of which more than 15 years is primarily focused on pharmaceutical (e.g., Hatch-Waxman), biotechnology, and medical device litigation. Pablo's litigation experience includes serving as lead counsel and ranges from prediscovery diligence to preliminary injunction proceedings, trial, and appeals involving patents, false advertising, trademark, trade secret misappropriation, and breach of contract.

Pablo has successfully represented clients in numerous pharmaceutical patent cases involving: ANDAs (abbreviated new drug applications) concerning inhalation medication for the treatment of asthma, improved oxycodene formulations, controlled release opioid analgesics, antifungul agents, and a niacin cholesterol-lowering drug; genetically modified mice; plasmid vectors; nutraceuticals; and autonomous medical imaging, infusion pumps, spinal fusion implants, corn herbicides, purge and trap concentrators for gas chromatography, and machine vision and bar code technologies. [1]